NIH-funded research R01 grant

Genetic factors beyond APOL1 and kidney transplant outcomes

Official title: Non-APOL1 genetic factors and kidney transplant outcomes

Funded at Columbia University Health Sciences · NIH-11372185 · Data updated 2026-11-12

This project tests whether genetic factors besides APOL1 influence how well kidney transplants last, using data from 2,800 donor-recipient pairs.

More Transplant research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 15, 2023
Project endMay 31, 2028
Funding year2026
Award (this year)$723,798
NIH project number5R01DK136765-04
Project IDNIH-11372185 on NIH RePORTER

Who could benefit from this research

Could help

Kidney transplant donor-recipient pairs enrolled in the APOLLO cohort, particularly individuals of African ancestry.

Less likely to help

Patients without access to APOLLO cohort data or not involved in kidney transplantation may not directly benefit.

What this research studies

If you or a loved one is involved in a kidney transplant, this study looks at the broader genetic makeup that may affect transplant success. Researchers will analyze genome-wide data from both donors and recipients in the APOLLO cohort to see which non-APOL1 genes might contribute to allograft outcomes. The goal is to improve prediction of transplant risk by combining donor polygenic information with APOL1 risk Genotypes. Results could help personalize risk assessment and long-term care for people of African ancestry who are disproportionately affected. This work builds on existing APOLLO findings and focuses on translating genetic insights into better transplant outcomes.

Why it matters

Potential benefit: Better lifelong prediction of transplant risk and more personalized care for kidney transplant patients, especially those of African ancestry.

How similar studies have gone: Prior work shows additive effects of polygenic risk and APOL1 on kidney disease, suggesting potential for improved prediction with GPS.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Kiryluk, Krzysztof — Columbia University Health Sciences
  • Study coordinator: Kiryluk, Krzysztof

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.